Publication

Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Tuesday, March 21, 2023

SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months and year ended December 31, 2022.

Key Points: 
  • For the year ended December 31, 2022, compared to the corresponding period of 2021, Semler Scientific reported:
    Revenue of $56.7 million, an increase of $3.7 million, or 7%, compared to $53.0 million.
  • Semler Scientific's two largest customers (including their affiliates) comprised 43.3% and 25.8% of fourth  quarter revenues in 2022.
  • For the quarter ended March 31, 2023, Semler Scientific expects continued profitability and generation of cash from operating activities.
  • The call will address results of the fourth quarter and year ended December 31, 2022, as well as provide a business update on Semler Scientific's market outlook and strategies for the near-term future.

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Tuesday, March 21, 2023

Revenues for the fourth quarter of 2022 were $1.424 million, compared to $0.436 million in the fourth quarter of 2021.

Key Points: 
  • Revenues for the fourth quarter of 2022 were $1.424 million, compared to $0.436 million in the fourth quarter of 2021.
  • Gross margin for the fourth quarter of 2022 was $0.300 million, compared to $(0.453) million in the fourth quarter of 2021.
  • Research and development expenses for the fourth quarter of 2022 were $5.219 million, compared to $8.893 million in the fourth quarter of 2021.
  • Sales, general, and administrative expenses for the fourth quarter of 2022 were $8.710 million, compared to $16.741 million in the fourth quarter of 2021.

Newsletters - March 2023 - Committee on Agriculture and Rural Development

Retrieved on: 
Tuesday, March 21, 2023

Access to page content (press "Enter")

Key Points: 
  • Access to page content (press "Enter")
    Direct access to language menu (press "Enter")
    Direct access to search menu (press "Enter")
    EN - English
    BG - български
    ES - español
    CS - čeština
    DA - dansk
    DE - Deutsch
    ET - eesti keel
    EL - Ελληνικά
    EN - English
    FR - français
    GA - Gaeilge
    HR - hrvatski
    IT - italiano
    LV - latviešu valoda
    LT - lietuvių kalba
    HU - magyar
    MT - Malti
    NL - Nederlands
    PL - polski
    PT - português
    RO - română
    SK - slovenčina
    SL - slovenščina
    FI - suomi
    SV - svenska
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Other websites
    Other websites
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Multimedia Centre
    President’s website
    Secretariat-general
    Think tank
    EP Newshub
    At your service
    Visits
    Legislative train
    Contracts and Grants
    Register
    Open Data Portal
    Committees
    European Parliament
    Search
    Search
    Please fill this field
    AGRI
    European Parliament
    Search
    Menu
    Choose your committee
    Choose your committee
    All committees - Homepage
    Foreign Affairs
    Human Rights
    Security and Defence
    Development
    International Trade
    Budgets
    Budgetary Control
    Economic and Monetary Affairs
    Tax Matters
    Employment and Social Affairs
    Environment, Public Health and Food Safety
    Industry, Research and Energy
    Internal Market and Consumer Protection
    Transport and Tourism
    Regional Development
    Agriculture and Rural Development
    Fisheries
    Culture and Education
    Legal Affairs
    Civil Liberties, Justice and Home Affairs
    Constitutional Affairs
    Women’s Rights and Gender Equality
    Petitions
    Beating Cancer
    COVID-19 pandemic: lessons learned and recommendations for the future
    Special Committee on foreign interference and disinformation, and on strengthening integrity in the EP
    Foreign Interference in all Democratic Processes in the European Union, including Disinformation
    Artificial Intelligence in a Digital Age
    Protection of Animals during Transport
    Use of Pegasus and equivalent surveillance spyware
    Go to the page
    AGRI
    Home
    Highlights
    Members
    Press releases
    Newsletters
    Publications
    Meetings
    Meeting documents
    Webstreaming
    Votes
    Minutes
    Documents
    Latest documents
    Motions for Resolution
    Search
    Work in progress
    Events
    Hearings
    Workshops
    Meetings with National Parliaments
    European Citizens’ Initiatives
    Supporting analyses
    Latest documents
    Search
    Presentation
    About
    Go back
    AGRI
    Home
    Newsletters
    March 2023
    March 2023
    Share this page on Facebook
    Share this page on Twitter
    Share this page on LinkedIn
    AGRI Newsletter nr 80 of 22-23 March 2023
    (PDF - 1 MB)

International Center for Peace Studies Hosts Discussion on Kashmir at the National Press Club

Retrieved on: 
Tuesday, March 21, 2023

WASHINGTON, March 21, 2023 /PRNewswire/ -- The International Center for Peace Studies is hosting a panel discussion: Kashmir - From Turmoil to Transformation: perspectives from the ground , on March 23 from 1-3 pm at the National Press Club in Washington, DC.

Key Points: 
  • WASHINGTON, March 21, 2023 /PRNewswire/ -- The International Center for Peace Studies is hosting a panel discussion: Kashmir - From Turmoil to Transformation: perspectives from the ground , on March 23 from 1-3 pm at the National Press Club in Washington, DC.
  • He made Kashmir University the first non-renewable energy base in Kashmir under the Solar Mission Policy of India.
  • The International Center for Peace Studies (ICPS) was started in 1993.
  • The Center has an Advisory Board of eminent experts, policymakers, academics, Vice Chancellors, former diplomats, administrators, and reputed Journalists.

Dassault Aviation: Availability of a complete form of the 2022 Annual Financial Report

Retrieved on: 
Tuesday, March 21, 2023

Dassault Aviation complete version of the 2022 Annual Financial Report (Rapport financier annuel) as of 31 December 2022 is available to the public and has been filed with the French Financial Markets Authority (Autorité des Marchés Financiers), including in ESEF format.

Key Points: 
  • Dassault Aviation complete version of the 2022 Annual Financial Report (Rapport financier annuel) as of 31 December 2022 is available to the public and has been filed with the French Financial Markets Authority (Autorité des Marchés Financiers), including in ESEF format.
  • This financial annual report can be found on the company’s website at www.dassault-aviation.com, in the “Finance / Regulated information / 2023” and “Finance / Publications / 2023 Publications” sections.

Three Westmount Partners Named to 2023 Leaders of Influence List

Retrieved on: 
Tuesday, March 21, 2023

LOS ANGELES, March 21, 2023 /PRNewswire/ -- Westmount Asset Management ("Westmount"), a Los Angeles-based, independent wealth management firm managing more than $4.5 billion in client assets, announced today that three firm leaders have been recognized as 2023 "Leaders of Influence" by the Los Angeles Business Journal: Jim Berliner (Chairman), Mike Amash (President), and Mike Cannone (Partner).

Key Points: 
  • LOS ANGELES, March 21, 2023 /PRNewswire/ -- Westmount Asset Management ("Westmount"), a Los Angeles-based, independent wealth management firm managing more than $4.5 billion in client assets, announced today that three firm leaders have been recognized as 2023 "Leaders of Influence" by the Los Angeles Business Journal: Jim Berliner (Chairman), Mike Amash (President), and Mike Cannone (Partner).
  • "This is the second year in a row that three Westmount professionals have been selected for this list of the most influential wealth managers in Los Angeles," says Sean Cauvel, CFP®, Managing Partner at Westmount.
  • "Their expertise, leadership, and dedication to their clients make them highly qualified for this recognition, and we're immensely proud of their achievements."
  • Those selected for inclusion were nominated by their peers and reviewed by the Los Angeles Business Journal's editorial department.

Research from Gartner® Predicts the Rise of Multiagent Orchestration Platforms to Direct Warehouse Robot Fleets

Retrieved on: 
Tuesday, March 21, 2023

GreyMatter matches robot agents according to work needs, including capacity and demand peaks, for seamless inventory orchestration.

Key Points: 
  • GreyMatter matches robot agents according to work needs, including capacity and demand peaks, for seamless inventory orchestration.
  • “Research from this Gartner report mentions the growing trend towards multiagent orchestration.
  • Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact.
  • Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

H1 Expands HCP Universe to Help Medical Affairs Understand and Track the Impact of Their Activities, Drive Adherence to Evidence-based Medicine, and Improve Patient Outcomes

Retrieved on: 
Tuesday, March 21, 2023

According to Johns Hopkins Medicine , evidence-based medicine is the cornerstone of clinical practice and can improve patient outcomes and quality of care.

Key Points: 
  • According to Johns Hopkins Medicine , evidence-based medicine is the cornerstone of clinical practice and can improve patient outcomes and quality of care.
  • HCP Universe will enable medical affairs teams to successfully engage HCPs and measure how their efforts are changing clinical behavior and improving patient outcomes.
  • We want the same because it will improve patient outcomes, quality of life, and access to equitable healthcare.
  • For more information on how H1 can help Medical Affairs track and measure impact, visit us here or to request a meeting with H1 during an upcoming conference, contact [email protected].

OcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity

Retrieved on: 
Tuesday, March 21, 2023

OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal.

Key Points: 
  • OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal.
  • By assessing the flavoprotein fluorescence in the retina with its flagship device, the OcuMet Beacon, these findings suggest that the novel FPF measure can detect retinal diseases with a high degree of sensitivity.
  • Mitochondrial dysfunction has been documented as a precursor to apoptosis, or cell death, and is implicated in many retinal diseases and disorders.
  • The OcuMet Beacon is currently being used under Institutional Review Board at New York Eye and Ear Infirmary at Mount Sinai.

Arlington Capital Partners Announces Formation of Eqlipse Technologies

Retrieved on: 
Tuesday, March 21, 2023

Arlington Capital Partners today announced the formation of Eqlipse Technologies (“Eqlipse” or the “Company”), which is expected to be effective as of the end of the first quarter, 2023.

Key Points: 
  • Arlington Capital Partners today announced the formation of Eqlipse Technologies (“Eqlipse” or the “Company”), which is expected to be effective as of the end of the first quarter, 2023.
  • “We are excited to announce the formation of Eqlipse, which is purpose-built to provide our essential national security agencies with the innovation they need as their missions evolve,” said David Wodlinger, a Managing Partner at Arlington Capital Partners.
  • Building on this distinguished R&D history, Eqlipse continues to mature the most promising research innovations into proprietary technologies with direct mission impact.
  • “The name Eqlipse communicates the total alignment of the Company’s innovative culture with the mission needs of our customers,” said Henry Albers, a Vice President at Arlington Capital Partners.